These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

328 related articles for article (PubMed ID: 29370683)

  • 1. Systematic review of the published data on the worldwide prevalence of John Cunningham virus in patients with multiple sclerosis and neuromyelitis optica.
    Paz SPC; Branco L; Pereira MAC; Spessotto C; Fragoso YD
    Epidemiol Health; 2018; 40():e2018001. PubMed ID: 29370683
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Longitudinal JCV serology in multiple sclerosis patients preceding natalizumab-associated progressive multifocal leukoencephalopathy.
    Vennegoor A; van Rossum JA; Polman CH; Wattjes MP; Killestein J
    Mult Scler; 2015 Oct; 21(12):1600-3. PubMed ID: 25662344
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-JC virus antibodies in a large German natalizumab-treated multiple sclerosis cohort.
    Trampe AK; Hemmelmann C; Stroet A; Haghikia A; Hellwig K; Wiendl H; Goelz S; Ziegler A; Gold R; Chan A
    Neurology; 2012 May; 78(22):1736-42. PubMed ID: 22592369
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-JC virus seroprevalence in a Finnish MS cohort.
    Kolasa M; Hagman S; Verkkoniemi-Ahola A; Airas L; Koivisto K; Elovaara I
    Acta Neurol Scand; 2016 May; 133(5):391-7. PubMed ID: 26347001
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serological profile of John Cunningham virus (JCV) in patients with multiple sclerosis.
    Branco LP; Adoni T; Apostolos-Pereira SL; Brooks JBB; Correa EC; Damasceno CA; Eboni ACB; Fezer L; Gama PDD; Goncalves MVM; Gomes S; Grzesiuk AK; Mendes MF; Morales RR; Muniz A; Parolin MFK; Pimentel MLV; Ribeiro MC; Santos GACD; Sato HK; Scherpenhuijzen SB; Scorcine C; Siquineli F; Sousa NAC; Varela DL; Winckler TCA; Fragoso YD
    Arq Neuropsiquiatr; 2018 Sep; 76(9):588-591. PubMed ID: 30365621
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A second-generation ELISA (STRATIFY JCV™ DxSelect™) for detection of JC virus antibodies in human serum and plasma to support progressive multifocal leukoencephalopathy risk stratification.
    Lee P; Plavina T; Castro A; Berman M; Jaiswal D; Rivas S; Schlain B; Subramanyam M
    J Clin Virol; 2013 Jun; 57(2):141-6. PubMed ID: 23465394
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-JCV serology during natalizumab treatment: Review and meta-analysis of 17 independent patient cohorts analyzing anti-John Cunningham polyoma virus sero-conversion rates under natalizumab treatment and differences between technical and biological sero-converters.
    Schwab N; Schneider-Hohendorf T; Hoyt T; Gross CC; Meuth SG; Klotz L; Foley JF; Wiendl H
    Mult Scler; 2018 Apr; 24(5):563-573. PubMed ID: 28847222
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Host cell virus entry mechanisms enhance anti-JCV-antibody switch in natalizumab-treated multiple sclerosis patients.
    Achiron A; Miron G; Zilkha-Falb R; Magalashvili D; Dolev M; Stern Y; Gurevich M
    J Neurovirol; 2016 Dec; 22(6):736-746. PubMed ID: 27170332
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence of Anti-JC Virus Antibody Seropositivity in Patients with Multiple Sclerosis: A Systematic Review and Meta-Analysis.
    Hanaei S; Sahraian MA; Mohammadifar M; Ramagopalan SV; Ghajarzadeh M; Ghajarzadeh M
    Intervirology; 2019; 62(5-6):169-173. PubMed ID: 32623436
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-JC virus antibodies in rituximab-treated patients with neuromyelitis optica spectrum disorder.
    Kim SH; Hyun JW; Jeong IH; Joung A; Yeon JL; Dehmel T; Adams O; Kieseier BC; Kim HJ
    J Neurol; 2015 Mar; 262(3):696-700. PubMed ID: 25559683
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Considerations on the appropriateness of the John Cunningham virus antibody assay use in patients with rheumatoid arthritis.
    Borie D; Kremer JM
    Semin Arthritis Rheum; 2015 Oct; 45(2):163-6. PubMed ID: 26190565
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-JCV antibody serostatus and longitudinal evaluation in a Portuguese Multiple Sclerosis population.
    Correia I; Jesus-Ribeiro J; Batista S; Martins AI; Nunes C; Macário MC; Cunha L; Sousa L
    J Clin Neurosci; 2017 Nov; 45():257-260. PubMed ID: 28844615
    [TBL] [Abstract][Full Text] [Related]  

  • 13. JCV epidemiology in MS (JEMS)--epidemiology of anti-JCV antibody prevalence in multiple sclerosis patients--Portuguese data.
    da Silva AM; Santos ME;
    J Neurol Sci; 2014 Feb; 337(1-2):119-22. PubMed ID: 24369270
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-JC virus (JCV) antibody prevalence in the JCV Epidemiology in MS (JEMS) trial.
    Bozic C; Subramanyam M; Richman S; Plavina T; Zhang A; Ticho B
    Eur J Neurol; 2014 Feb; 21(2):299-304. PubMed ID: 24894998
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-JC virus antibody prevalence in a multinational multiple sclerosis cohort.
    Olsson T; Achiron A; Alfredsson L; Berger T; Brassat D; Chan A; Comi G; Eraksoy M; Hegen H; Hillert J; Jensen PE; Moiola L; Myhr KM; Oturai A; Schippling S; Siva A; Sorensen PS; Trampe AK; Weber T; Potts J; Plavina T; Paes D; Subramanyam M; Wiendl H; Dib H; Uren D; Hemmer B; Buck D
    Mult Scler; 2013 Oct; 19(11):1533-8. PubMed ID: 23459571
    [TBL] [Abstract][Full Text] [Related]  

  • 16. John Cunningham virus conversion in relation to natalizumab concentration in multiple sclerosis patients.
    van Kempen ZLE; Leurs CE; de Vries A; Vennegoor A; Rispens T; Wattjes MP; Killestein J
    Eur J Neurol; 2017 Sep; 24(9):1196-1199. PubMed ID: 28707781
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of plasma exchange on serum anti-JC virus antibodies.
    Subramanyam M; Plavina T; Khatri BO; Fox RJ; Goelz SE
    Mult Scler; 2013 Jun; 19(7):912-9. PubMed ID: 23232602
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Study of the anti-JCV antibody levels in a Spanish multiple sclerosis cohort.
    Dominguez-Mozo MI; Rus M; Santiago JL; Izquierdo G; Casanova I; Galan V; Garcia-Martinez MA; Arias-Leal AM; García-Montojo M; Pérez-Pérez S; Arroyo R; Alvarez-Lafuente R
    Eur J Clin Invest; 2017 Feb; 47(2):158-166. PubMed ID: 28036121
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The value of anti-JCV antibody index assessment in multiple sclerosis patients treated with natalizumab with respect to demographic, clinical and radiological findings.
    Kolcava J; Hulova M; Benesova Y; Bednarik J; Stourac P
    Mult Scler Relat Disord; 2019 May; 30():187-191. PubMed ID: 30785075
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of tonsillectomy on John Cunningham virus serological status in multiple sclerosis patients: A retrospective case-control study.
    Avila M; Okai A; Thakolwiboon S; O'Bryan C; Reddy Gopireddy MM; Gorantla S
    Mult Scler; 2021 Jul; 27(8):1297-1300. PubMed ID: 33179571
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.